This study, called G-COR, is collecting information from 5000 people to better understand how cancer treatments affect the heart. It focuses on patients with breast cancer, certain blood cancers (like lymphoma and leukemia), and those receiving immunotherapy (immune checkpoint inhibitors). The study will gather anonymous health information, including demographics, medical history, imaging results, lab tests, cancer treatments, and any heart-related events. The main goals are to identify risk factors for heart problems caused by cancer treatments and to develop tools to predict these risks. You might be able to join if you are 18 or older and are having a new consultation with a cardio-oncology specialist for one of the specified cancer types.

Study design

This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to include 5000 participants.

What's involved

You would allow researchers to collect your anonymous health data during your regular clinical follow-up appointments.

Compensation

Not stated in the trial record.

Follow-up

Researchers will track cardiotoxicity, new cardiovascular events, and cardiovascular death for 18 months after you join the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.